TGF-β1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner
TGF-β1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner
复制标题
DOI:
10.1016/j.prostaglandins.2007.11.004
复制
发表时间:
2008-03-01
影响因子:
2.9
通讯作者:
Hewett, Sandra J.
中科院分区:
文献类型:
--
作者:
Hamby, Mary E.;Hewett, James A.;Hewett, Sandra J.
Transforming growth factor-beta 1 (TGF-beta 1) is upregulated by inflammatory mediators in several neurological diseases/disorders where it either participates in the pathology or provides protection. Often, the biological outcome of TGF-beta 1 is dependent upon changes in gene expression. Recently, we demonstrated that TGF-beta 1 enhances astrocytic nitric oxide production induced by lipopolysaccharide (LPS) plus interferon-gamma (IFN gamma) by increasing the number of astrocytes in a population that express NOS-2. The purpose of this study was twofold: (1) to determine whether this effect occurs more generally by assessing the effect of TGF-beta 1 on another pro-inflammatory gene, cyclooxygenase-2 (COX-2); and (2) to assess stimulus specificity. We found that TGF-beta 1 augmented LPS plus IFN gamma-induced COX-2 mRNA and protein expression, by nearly tripling the number of astrocytes that express COX-2. The effect was not stimulus-specific as TGF-beta 1 enhanced the number of astrocytes that expressed both COX-2 and NOS-2 protein when either IL-1 beta or TNF alpha was used in lieu of LPS. Collectively, these results suggest that TGF-beta 1 augments overall protein expression levels of select pro-inflammatory genes in astrocytes in a promiscuous manner by reducing the magnitude of noise in the cellular population. (C) 2007 Elsevier Inc. All rights reserved.